Mucus Relief Tablet
Product Images NDC 11822-3252

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 1 technical images submitted to the FDA as part of the official labeling for Mucus Relief (NDC 11822-3252). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Rite Aid Corporation, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Guaifenesin 600 mg (Mucus Relief 600 mg Extended Release Tablets 1)

Guaifenesin 600 mg (Mucus Relief 600 mg Extended Release Tablets 1)
This is a drug fact sheet for an extended-release tablet containing Guaifenesin 600 mg which is used as an expectorant to help loosen mucus and thin bronchial secretions for the temporary relief of chest congestion. It should not be used by children under 12 years of age and precautions should be taken by pregnant and breastfeeding women. If cough persists for more than 7 days, stops and starts again or is accompanied by a severe headache or back pain, a physician should be consulted. The recommended dose for adults and children over 12 years of age is 1 or 2 tablets every 12 hours and should not exceed 4 tablets per 24 hours. The tablets should be swallowed whole with a full glass of water and not crushed or broken. The inactive ingredients are listed on the package and Rite Aid is the distributor of this product.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.